Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Communication
  • Published:

Biochemical deficiency of pyridoxine does not affect interleukin-2 production of lymphocytes from patients with Sjögren's syndrome

Abstract

Background: There is evidence that pyridoxine deficiency may alter the immune response. It is not known whether a deficiency of this vitamin is evident in subjects with primary Sjögren's syndrome (SS).

Objective: We studied whether subjects with primary SS showed a biochemical deficiency of pyridoxine, and if it is associated with abnormal production of interleukin-2 from lymphocytes stimulated in vitro with phytohemagglutinin (PHA).

Design: Two studies were conducted, (i) biochemical and nutritional assessments were performed in a cross-over study in subjects with primary SS, who were supplemented with 25 mg/day of pyridoxine or placebo for 3 months. After 1 month washout, they were supplemented for 3 months with placebo, (ii) patients with SS and matched controls received pyridoxine or placebo for 45 days, and a blood sample was obtained to study IL-2 production and expression in T-lymphocytes stimulated with PHA.

Results: Subjects with primary SS showed limited dietary intake of pyridoxine and biochemical deficiency of this vitamin assessed through the activation coefficient of the erythrocyte aspartate aminotransferase. The biochemical deficiency did not affect production nor mRNA expression of IL-2 from T-lymphocytes stimulated in vitro with PHA compared with the control group. Supplementation of subjects with primary SS with 25 mg/day with pyridoxine for 45 days did not produce any significant change as compared to those patients supplemented with placebo.

Conclusions: Subjects with primary SS showed biochemical deficiency of pyridoxine, possibly due to limited intake of this vitamin which was corrected by supplementation with pyridoxine. However, IL-2 production and mRNA expression from stimulated lymphocytes were unaffected by supplementation, probably because the deficiency was not severe enough to affect the immune system.

Sponsorship: This work was supported by the National Council of Science and Technology (CONACYT), Mexico, grant no. 212226-5-0902PM.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Ahmed SA, Penhale WJ, Talal N . 1985 Sex hormones, immune responses and autoimmune diseases Am. J. Pathol. 121: 531–551

    CAS  Google Scholar 

  • Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S . 1993 Cytokine profile in systematic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases J. Clin. Immunol. 1: 58–67

    Article  Google Scholar 

  • Alarcón-Segovia D . 1989 Primary Sjögren's syndrome: six characters in search of an author J. Rheumatol. 16: 1177–1178

    PubMed  Google Scholar 

  • Alcocer-Varela J, Laffon A, Alarcón-Segovia D . 1984 Differences in the production of and/or the response to interleukin-2 by T-lymphocytes from patients with the various connective tissue diseases Rheumatol. Int. 4: 39–44

    Article  CAS  Google Scholar 

  • Alvarez-Celorio MA, Angeles-Angeles A, Kraus A . 2000 Primary Sjögren's syndrome and celiac disease J. Clin. Rheumatol. 6: 194–197

    Article  CAS  Google Scholar 

  • Axelrod AE, Trakatellis AC . 1964 Relationship of pyridoxine to immunological phenomena Vitam. Horm. 22: 591–607

    Article  CAS  Google Scholar 

  • Aziz KE, McCluskey PJ, Wakefield D . 1994 Phenotypic and functional abnormalities in the peripheral blood T-cells of patients with primary Sjögren's syndrome Cytometry 15: 35–41

    Article  Google Scholar 

  • Beisel W . 1982 Single nutrients and immunity Am. J. Clin. Nutr. 35: (Suppl): 417–468

    Article  CAS  Google Scholar 

  • Beisel W . 1990 Vitamins and the immune system Ann. NY Acad. Sci. 587: 5–8

    Article  CAS  Google Scholar 

  • Bhalla AK . 1989 Hormones and the immune response Ann. Rheum. Dis. 48: 1–6

    Article  CAS  Google Scholar 

  • Boumba D, Skopouli FN, Moutsopoulos HM . 1995 Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome Br. J. Rheumatol. 34: 326–333

    Article  CAS  Google Scholar 

  • Boyum A . 1968 Isolation of mononuclear cells and granulocytes from human blood Scan. J. Clin. Lab. Invest. 21: (Suppl): 77–89

    CAS  Google Scholar 

  • Chandra RK . 1991 Nutrition and immunity: lessons from the past and new insights into the future Am. J. Clin. Nutr. 53: 1087–1101

    Article  CAS  Google Scholar 

  • Chandra R, Au B, Heresi G . 1981 Single nutrient deficiency and cell-mediated immune responses. II. Pyridoxine Nutr. Res. 1: 101–106

    Article  CAS  Google Scholar 

  • Chomczynski P . 1993 A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples Bio Techniques 15: 532–536

    CAS  Google Scholar 

  • Coligan JE, Kruisbeek AM, Margulis DH, Sheavach EM, Strober W . 1992 Current Protocols in Immunology New York: John Wiley & Sons

    Google Scholar 

  • Daniels TE, Talal N . 1987 Diagnosis and differential diagnosis of Sjögren's syndrome In Sjögren's Syndrome. Clinical and Immuno-logical Aspects eds. N Talal, HM Moutsopoulos & SS Kassan, pp 150–165 Germany: Springer-Verlag

    Google Scholar 

  • Fox RI, Robinson C, Curd JC, Michelson P, Kozin F, Howell FV . 1986 Sjögren's syndrome: proposed criteria for classification Athritis Rheum. 29: 577–585

    Article  CAS  Google Scholar 

  • Harbige LS . 1996 Nutrition and immunity with emphasis on infection and autoimmune disease Nutr. Health 10: 285–312

    Article  CAS  Google Scholar 

  • Hernandez M, Chavez A, Bourges H . 1977 Valor Nutritivo de los Alimentos Mexicanos Mexico: Publication L-12 de la División de Nutrición, Instituto Nacional de la Nutricion

    Google Scholar 

  • Horrobin D . 1984 Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjögren's syndrome Med. Hypoth. 14: 233–247

    Article  CAS  Google Scholar 

  • Horrobin D . 1986 Essential fatty acid and prostaglandin metabolism in Sjögren's syndrome, systematic sclerosis and rheumatoid arthritis Scand. J. Rheumatol. 61: (Suppl): 242–245

    CAS  Google Scholar 

  • Horrobin D, Campbell A . 1980 Sjögren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C Med. Hypoth. 6: 225–232

    Article  CAS  Google Scholar 

  • Horrobin DF, Oka M, Manku MS . 1979 The regulation of prostaglandin E1 formation: a candidate for one of the fundamental mechanisms involved in the actions of vitamin C Med. Hypoth. 5: 849–858

    Article  CAS  Google Scholar 

  • Horrobin D, Campbell A, McEwan CG . 1981 Treatment of the sicca syndrome and Sjögren's syndrome with EFA, pyridoxine and vitamin C Prog. Lipid Res. 20: 253–254

    Article  CAS  Google Scholar 

  • Karmen A . 1955 A note on the spectrophotometric assay for glutamic oxaloacetic transaminase in human blood serum J. Clin. Invest. 34: 131–133

    Article  CAS  Google Scholar 

  • Kater L, deWilde PCM . 1992 New developments in Sjögren's syndrome Curr. Opin. Rheumatol. 4: 657–665

    CAS  PubMed  Google Scholar 

  • Kraus A, Caballero-Uribe C, Jakez J, Villa A, Alarcón-Segovia D . 1992 Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations J. Rheumatol. 19: 1572–1574

    CAS  PubMed  Google Scholar 

  • Kroemer G, Martínez AC . 1991 Cytokines and autoimmune disease Clin. Immunol. Immunopathol. 61: 275–295

    Article  CAS  Google Scholar 

  • Leklem J . 1990 Vitamin B-6: a status report J. Nutr. 120: 1503–1507

    Article  CAS  Google Scholar 

  • Manthrope R, Oxholm P, Prause JU, Schiødt M . 1986 The Copenhagen criteria for Sjögren's syndrome Scand. J. Rheumatol. 61: (Suppl): 19–21

    Google Scholar 

  • Meydani SN, Ribaya-Mercado JD, Russell RM, Sahyoun N, Morrow D, Gershoff SN . 1991 Vitamin B-6 impairs interleukin 2 production and lymphocyte proliferation in elderly adults Am. J. Clin. Nutr. 53: 1275–1280

    Article  CAS  Google Scholar 

  • Moriuchi J, Ichikawa Y, Takaya M, Shimizu H, Tsuji K, Wakisaka A, Dawkins R, Arimori S . 1991 Association of the complement allele C4AQO with primary Sjögren's syndrome in Japanese patients Arthritis Rheum. 34: 224–227

    Article  CAS  Google Scholar 

  • Pettersson T, Metsärinne K, Teppo AM, Fyhrquist F . 1992 Immunoreactive interleukine-6 in serum of patients with B-lymphoproliferative diseases J. Intern. Med. 232: 439–442

    Article  CAS  Google Scholar 

  • Rall LC, Meydani SN . 1993 Vitamin B6 and immune competence Nutr. Rev. 51: 217–225

    Article  CAS  Google Scholar 

  • Ravn P, Linnet J, Klokker M, Pedersen BK . 1995 Effects of isoniazid treatment on human lymphocyte proliferative response, lymphocyte subsets and natural killer cell activity Immunopharmacology 30: 247–253

    Article  CAS  Google Scholar 

  • Reveille JD . 1992 The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome Curr. Opin. Rheumatol. 4: 644–656

    CAS  PubMed  Google Scholar 

  • Salvarani C, Machioni P, Lodi P, lori I, Bolardi L, Bertorelli G, Rossi F, Panciroli G, Portioli I . 1991 Sjögren's syndrome in human immunodeficiency virus (HIV) infection: association with HLA-DR3 and CD8 lymphocytosis in an Italian patient Clin. Exp. Rheumatol. 90: 286–294

    Google Scholar 

  • Shiozawa S, Shizawa K, Shimizu S . 1990 Immuno reactive circulating alpha-interfon is low in Sjögren's syndrome Br. J. Rheumatol. 29: 50–52

    Article  CAS  Google Scholar 

  • Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcón-Segovia D, Kraus A . 1998 Oral candidiasis and Sjögren's Syndrome J. Rheumatol. 25: 911–915

    CAS  PubMed  Google Scholar 

  • Stanulovic M, Miletic D, Stock A . 1967 The diagnosis of pyridixine deficiency based on the estimation of erythrocytic aspartate aminotransferase and its stimulation in vitro with pyridoxal-5-phosphate Clin. Chem. Acta 17: 353–362

    Article  CAS  Google Scholar 

  • Struyf N, Snoeck H, Bridts C, De Clerck L, Stevens J . 1990 Natural killer cell activity in Sjögren's syndrome and systematic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes Ann. Rheum. Dis. 49: 690–693

    Article  CAS  Google Scholar 

  • Talbott M, Miller L, Kerkvliet N . 1987 Pyridoxine supplementation: effect on lymphocyte responses in elderly persons Am. J. Clin. Nutr. 46: 659–664

    Article  CAS  Google Scholar 

  • Tovar A, Bourges H, Canto T, Torres N, López-Castro B . 1985 Effect of oral contraceptive use on the erythrocyte glutathione reductase and aspartate aminotransferase activities in women with or without clinical signs of vitamin deficiency Nutr. Rep. Int. 32: 199–209

    CAS  PubMed  Google Scholar 

  • Tovar AR, Torres N, Halhali A, Bourges H . 1996 Riboflavin and pyridoxine status in a group of pregnant Mexican women Arch. Med. Res. 27: 195–200

    CAS  PubMed  Google Scholar 

  • Trakatellis A, Dimitriadou A, Exindari M, Scountzou J, Koliakos G, Christododoulou D, Malissiovas N, Antoniadis A, Polyzoni T . 1992 Effect of pyridoxine deficiency on immunological phenomena Postgrad. Med. J. 68: (Suppl 1): S70–S77

    CAS  PubMed  Google Scholar 

  • U.S. Department of Agriculture. 1985 Nutrient data base for standard reference expansion of data published in composition of foods, raw. Processed, prepared (Revision of USDA Handbook 8-1 tp 8-16) Washington, DC: U.S. Goverment Printing Office

  • Van den Berg H, Mulder J, Spanhaak S, Dokkum WV, Ockhuizen T . 1998 In The Influence of Marginal B-6 Status on Immunological Indicies eds. JE Leklem & RD Reynold, pp 147–155 New York: A.R. Liss Inc.

    Google Scholar 

  • Vitali C, Bombardieri S, Moutsopoulus HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB . 1993 Preliminary criteria for the classification of Sjögren's syndrome Arthrits Rheum. 36: 340–347

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge Productos Roche de México for the donation and manufacture of the pyridoxine supplement.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to AR Tovar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tovar, A., Gómez, E., Bourges, H. et al. Biochemical deficiency of pyridoxine does not affect interleukin-2 production of lymphocytes from patients with Sjögren's syndrome. Eur J Clin Nutr 56, 1087–1093 (2002). https://doi.org/10.1038/sj.ejcn.1601450

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1601450

Keywords

This article is cited by

Search

Quick links